A PANCREATIC cancer campaigner from Scunthorpe has expressed her disappointment after the health spending watchdog for England refused to fund a new drug.
The National Institute for Health and Care Excellence (NICE) has today confirmed its ruling that Abraxane is too expensive to be given alongside gemcitabine.
This is despite it being shown to extend life-expectancy by two months, and for significantly longer in some patients.
Maggie Watts, who lost her husband Kevin to pancreatic cancer in...
